Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells

BACKGROUND: Melanoma is the most aggressive and deadly form of skin cancer with increasing case numbers worldwide. The development of inhibitors targeting mutated BRAF (found in around 60% of melanoma patients) has markedly improved overall survival of patients with late-stage tumors, even more so w...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Exp Clin Cancer Res
Egile Nagusiak: Margue, Christiane, Philippidou, Demetra, Kozar, Ines, Cesi, Giulia, Felten, Paul, Kulms, Dagmar, Letellier, Elisabeth, Haan, Claude, Kreis, Stephanie
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2019
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6364417/
https://ncbi.nlm.nih.gov/pubmed/30728057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-019-1038-x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak